Ercros Past Earnings Performance

Past criteria checks 1/6

Ercros has been growing earnings at an average annual rate of 12.5%, while the Chemicals industry saw earnings growing at 12.4% annually. Revenues have been growing at an average rate of 8.7% per year. Ercros's return on equity is 7.9%, and it has net margins of 4%.

Key information

12.5%

Earnings growth rate

13.8%

EPS growth rate

Chemicals Industry Growth13.1%
Revenue growth rate8.7%
Return on equity7.9%
Net Margin4.0%
Next Earnings Update30 May 2024

Recent past performance updates

Recent updates

Estimating The Intrinsic Value Of Ercros, S.A. (BME:ECR)

Mar 02
Estimating The Intrinsic Value Of Ercros, S.A. (BME:ECR)

At €2.75, Is It Time To Put Ercros, S.A. (BME:ECR) On Your Watch List?

Dec 20
At €2.75, Is It Time To Put Ercros, S.A. (BME:ECR) On Your Watch List?

Here's Why Ercros (BME:ECR) Has A Meaningful Debt Burden

Nov 10
Here's Why Ercros (BME:ECR) Has A Meaningful Debt Burden

Here's Why Ercros (BME:ECR) Can Manage Its Debt Responsibly

Apr 26
Here's Why Ercros (BME:ECR) Can Manage Its Debt Responsibly

Ercros (BME:ECR) Will Be Hoping To Turn Its Returns On Capital Around

Mar 07
Ercros (BME:ECR) Will Be Hoping To Turn Its Returns On Capital Around

Why Ercros, S.A. (BME:ECR) Could Be Worth Watching

Jan 25
Why Ercros, S.A. (BME:ECR) Could Be Worth Watching

Should You Investigate Ercros, S.A. (BME:ECR) At €3.71?

Sep 07
Should You Investigate Ercros, S.A. (BME:ECR) At €3.71?

A Look At The Fair Value Of Ercros, S.A. (BME:ECR)

Jun 09
A Look At The Fair Value Of Ercros, S.A. (BME:ECR)

Here's Why Ercros (BME:ECR) Has A Meaningful Debt Burden

May 23
Here's Why Ercros (BME:ECR) Has A Meaningful Debt Burden

Should Ercros, S.A. (BME:ECR) Be Part Of Your Dividend Portfolio?

May 05
Should Ercros, S.A. (BME:ECR) Be Part Of Your Dividend Portfolio?

Should You Think About Buying Ercros, S.A. (BME:ECR) Now?

Mar 12
Should You Think About Buying Ercros, S.A. (BME:ECR) Now?

Is Ercros (BME:ECR) A Future Multi-bagger?

Feb 22
Is Ercros (BME:ECR) A Future Multi-bagger?

Here's Why Ercros (BME:ECR) Has A Meaningful Debt Burden

Feb 05
Here's Why Ercros (BME:ECR) Has A Meaningful Debt Burden

Read This Before Buying Ercros, S.A. (BME:ECR) For Its Dividend

Jan 20
Read This Before Buying Ercros, S.A. (BME:ECR) For Its Dividend

Is Ercros, S.A.'s (BME:ECR) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Jan 05
Is Ercros, S.A.'s (BME:ECR) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Calculating The Intrinsic Value Of Ercros, S.A. (BME:ECR)

Dec 18
Calculating The Intrinsic Value Of Ercros, S.A. (BME:ECR)

Shareholders Of Ercros (BME:ECR) Must Be Happy With Their 257% Total Return

Nov 29
Shareholders Of Ercros (BME:ECR) Must Be Happy With Their 257% Total Return

Revenue & Expenses Breakdown
Beta

How Ercros makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BME:ECR Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23726291410
30 Sep 23815211420
30 Jun 23909381460
31 Mar 23980661470
31 Dec 221,026711450
30 Sep 221,033681480
30 Jun 22962791360
31 Mar 22893521360
31 Dec 21790491310
30 Sep 2171428910
30 Jun 21652221460
31 Mar 2159014890
31 Dec 2057161240
30 Sep 2057318880
30 Jun 2060325900
31 Mar 2064528880
31 Dec 1967131890
30 Sep 1968226940
30 Jun 1968127860
31 Mar 1967939910
31 Dec 1867245830
30 Sep 1868047880
30 Jun 1867649850
31 Mar 1868245930
31 Dec 1768145920
30 Sep 1766352950
30 Jun 1764449980
31 Mar 1762646910
31 Dec 1660345910
30 Sep 1660829810
30 Jun 1661321870
31 Mar 1662015810
31 Dec 156187870
30 Sep 15609-3790
30 Jun 15612-3800
31 Mar 15606-4790
31 Dec 14604-7790
30 Sep 146084800
30 Jun 146084760
31 Mar 146174800
31 Dec 136250800
30 Sep 13658-8870
30 Jun 13615-8860

Quality Earnings: ECR has a large one-off gain of €3.5M impacting its last 12 months of financial results to 31st December, 2023.

Growing Profit Margin: ECR's current net profit margins (4%) are lower than last year (6.9%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ECR's earnings have grown by 12.5% per year over the past 5 years.

Accelerating Growth: ECR's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: ECR had negative earnings growth (-59.2%) over the past year, making it difficult to compare to the Chemicals industry average (-19%).


Return on Equity

High ROE: ECR's Return on Equity (7.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.